- Home
- ESPR vs BRDG Comparison
ESPR vs BRDG Comparison
Compare ESPR & BRDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- BRDG
- Stock Information
- Founded
- ESPR 2008
- BRDG 2009
- Country
- ESPR United States
- BRDG United States
- Employees
- ESPR N/A
- BRDG N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- BRDG Investment Managers
- Sector
- ESPR Health Care
- BRDG Finance
- Exchange
- ESPR Nasdaq
- BRDG Nasdaq
- Market Cap
- ESPR 305.0M
- BRDG 391.6M
- IPO Year
- ESPR 2013
- BRDG 2021
- Fundamental
- Price
- ESPR $0.89
- BRDG $9.41
- Analyst Decision
- ESPR Buy
- BRDG Hold
- Analyst Count
- ESPR 7
- BRDG 5
- Target Price
- ESPR $5.93
- BRDG $11.00
- AVG Volume (30 Days)
- ESPR 5.7M
- BRDG 189.0K
- Earning Date
- ESPR 05-06-2025
- BRDG 05-20-2025
- Dividend Yield
- ESPR N/A
- BRDG 4.87%
- EPS Growth
- ESPR N/A
- BRDG N/A
- EPS
- ESPR N/A
- BRDG 0.13
- Revenue
- ESPR $259,574,000.00
- BRDG $419,220,000.00
- Revenue This Year
- ESPR $5.70
- BRDG N/A
- Revenue Next Year
- ESPR N/A
- BRDG $25.81
- P/E Ratio
- ESPR N/A
- BRDG $72.49
- Revenue Growth
- ESPR 12.99
- BRDG 61.35
- 52 Week Low
- ESPR $0.82
- BRDG $6.56
- 52 Week High
- ESPR $3.94
- BRDG $11.69
- Technical
- Relative Strength Index (RSI)
- ESPR 36.95
- BRDG 53.17
- Support Level
- ESPR $0.93
- BRDG $9.01
- Resistance Level
- ESPR $1.11
- BRDG $9.84
- Average True Range (ATR)
- ESPR 0.10
- BRDG 0.31
- MACD
- ESPR 0.02
- BRDG 0.02
- Stochastic Oscillator
- ESPR 25.10
- BRDG 72.17
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About BRDG Bridge Investment Group Holdings Inc.
Bridge Investment Group Holdings Inc is a vertically integrated investment manager, diversified across specialized asset classes. The company combines its operating platform with dedicated teams of investment professionals focused on various specialized and synergistic investment platforms, including real estate, credit, renewable energy, and secondaries strategies. Its products and vertically integrated structure allow it to capture new market opportunities and serve investors with various investment objectives. The Company operates as one business, a fully integrated real estate investment manager.